Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 4 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Breast Neoplasms 2768Carcinoma, Non-Small-Cell Lung 2267Prostatic Neoplasms 1427Colorectal Neoplasms 1295Neoplasms 1260Multiple Myeloma 1086Lung Neoplasms 1050Neoplasm Metastasis 995Leukemia, Myeloid, Acute 985Lymphoma 900Melanoma 864Pancreatic Neoplasms 819Ovarian Neoplasms 805Carcinoma, Hepatocellular 782Stomach Neoplasms 754Recurrence 753Leukemia 733Lymphoma, Non-Hodgkin 685Leukemia, Lymphocytic, Chronic, B-Cell 665Squamous Cell Carcinoma of Head and Neck 618Lymphoma, Large B-Cell, Diffuse 617Precursor Cell Lymphoblastic Leukemia-Lymphoma 605Head and Neck Neoplasms 599Brain Neoplasms 593Carcinoma, Renal Cell 587Glioblastoma 573Rectal Neoplasms 565Sarcoma 523Myelodysplastic Syndromes 522Lymphoma, Follicular 516

Interventions

Pemetrexed 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Interventional × Pericardial Effusion × Clear all
NCT02054052 2019-03-29

Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer

Guangzhou Medical University

Phase 2 Completed
22 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Pericardial Effusion, Pleural Effusion, Malignant

NCT00508144 2017-02-13

Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
64 enrolled 5 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pericardial Effusion, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡